2-CARBOMETHOXY-3-TROPINONE CAS: 36127-17-0

CAS NO: 36127-17-0
2-CARBOMETHOXY-3-TROPINONE
Chemical Name: 2-CARBOMETHOXY-3-TROPINONE
Molecular Formula: C10H15NO3
Formula Weight: 197.23
CAS No.: 36127-17-0
Description Review
Description

2-Carbomethoxy-3-tropinone is a chemical compound that belongs to the class of tropane alkaloids. It's also known by other names such as Methyl ecgonine, Tropacocaine, and Benzoylecgonine. The chemical name of this compound is (1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-one-2-carboxylate, its molecular formula is C13H17NO3, and its formula weight is 235.28 g/mol. Its CAS number is 36127-17-0.

Top ten keywords from Google and synonyms:

  1. Tropacocaine
  2. Methyl ecgonine
  3. Benzoylecgonine
  4. Tropane alkaloid
  5. Cocaine analogue
  6. Synthetic drugs
  7. Controlled substance
  8. Drug testing
  9. Urine analysis
  10. Drug abuse

Health benefits of this product:

There are no known health benefits of consuming or using 2-Carbomethoxy-3-tropinone. In fact, it's classified as a controlled substance because of its potential for misuse and abuse. The consumption of this compound can lead to various adverse effects on the body.

Potential effects:

The consumption of 2-Carbomethoxy-3-tropinone can cause various effects on the body, including:

  1. Euphoria: One of the most common effects associated with this compound is a feeling of euphoria or intense happiness.

  2. Increased sociability: Users may feel more talkative and sociable while under the influence of this compound.

  3. Increased energy: Consumption of this compound can lead to a temporary increase in energy levels.

  4. Numbness: Some users may experience numbness in certain parts of their body while under the influence of this compound.

Product mechanism:

2-Carbomethoxy-3-tropinone is a cocaine analogue, meaning that it has a similar chemical structure and mechanism of action to cocaine. It works by inhibiting the reuptake of dopamine in the brain, leading to an increase in the concentration of this neurotransmitter in the synapse. This ultimately leads to the feeling of euphoria and increased energy associated with the consumption of this compound.

Safety:

2-Carbomethoxy-3-tropinone is a controlled substance that has the potential for misuse and abuse. Its consumption can lead to various adverse effects on the body, including neurological and cardiovascular problems. Additionally, it's important to note that its production and distribution are illegal in many countries.

Side effects:

The consumption of 2-Carbomethoxy-3-tropinone can lead to various adverse effects on the body, including:

  1. Cardiovascular problems: Consumption of this compound can lead to an increased risk of heart attack, stroke, and other cardiovascular problems.

  2. Neurological problems: It can lead to neurological problems such as seizures, tremors, and even coma.

  3. Psychological problems: Individuals who consume this compound may experience anxiety, depression, paranoia, and other psychological problems.

Dosing information:

There is no recommended dose for 2-Carbomethoxy-3-tropinone because of its illegal status and potential for misuse and abuse. Any consumption of this compound is considered illegal and can lead to legal repercussions.

Conclusion:

In conclusion, 2-Carbomethoxy-3-tropinone is a cocaine analogue that's classified as a controlled substance because of its potential for misuse and abuse. Its consumption can lead to various adverse effects on the body, including neurological and cardiovascular problems. The production and distribution of this compound are illegal in many countries, and any consumption of this compound is considered illegal and can lead to legal repercussions. It's important to avoid the use of this compound and seek help if you or someone you know is struggling with drug abuse

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code